The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157: Miracle Healing Peptide or Hidden Danger? RFK Jr. promotes peptides. Now the FDA weighs easing limits on the unproven chemicals Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law